For world #TB day my talented daughter Edden Av-Gay painted a Mycobacterium tuberculosis colony and an RFP strain within macrophages, inspired by my lab images.
@baym Thats if you believe in Lamark’s theory. As the mutations pool pre existing to the antibiotics treatment you only select for pre existing resistors. So your suggested “common sense” is not a “simple logic”. See TB as an example.
@Elishahaas1 הביקורת על הממשלה היתה בקונטקסט של הפגיעה החמורה בהשכלה הגבוהה. זו לא רק זכותו זו חובתו של נשיא האקדמיה להשמיע קול זעקה. הוא הפריד בצורה חכמה בין אנטישמיות, אנטי ציונות שהוא גינה לבין ביקורת על הממשלה הנוכחית שהיא רעה מאוד לאקדמיה.
CIHR funding rate: 13.6%.
Early 2000s: 30%+.
Canada’s new $1.7B Impact+ program recruits talent — but without increased Tri-Council base funding, we risk further strain on an already stretched system.
We’re calling for $1B over 5 years.
Support here: https://t.co/iknRwlOqvM
Congratulations @Leahisobella from now on to be known as Dr. Rankin-Wilson. You had an awesome Phd defence and an amazing thesis. So proud of you! @UBCMicroImmuno
🇨🇦Yossef Av-Gay
Departamento de Microbiología e
Inmunología. Facultad de Medicina, División de
Enfermedades Infecciosas, Univ. de Columbia Británica
🇨🇦Yossef Av-Gay. Dep. of Microbiology and
Immunology. Faculty of Medicine, Division of
Infectious Diseases, U. of British Columbia
Hot from the press! Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria | Antimicrobial Agents and Chemotherapy https://t.co/jA9QBPcJaF. Thank you Leah abd team at @UBCMicroImmuno@Leahisobella@tiroshShapira@henok_sahile@SunLabTB
Julian Davies memorial Symposium. There is still time to register to attend online! If you would like to participate virtually, please complete this form: https://t.co/8MJEHGok4h
The agenda for the Julian Davies Memorial Symposium is now available!: https://t.co/TlifzQD1Bx
Please complete this form by September 10 to register to attend: https://t.co/55NBMaukTL @UBCMicroImmuno@UBC
In Memoriam: Dr. Neil Reiner (Division of Infectious Diseases) | Department of Medicine. @UBC in honour of a great mentor, colleague and friend. RIP Neil https://t.co/zrekY7OZNB
A 70-year-old Parkinson’s drug may offer new hope against tuberculosis by boosting the body’s immune defences, finds a new UBC study.
Learn more: https://t.co/M42uvRLT8s
Researchers in the Av-Gay lab (@yossiavgay) at @UBCMicroImmuno have identified benztropine, an approved Parkinson’s disease drug, as a potent inhibitor of Mycobacterium #tuberculosis. 💊
Check out the new paper in @npjAMR: https://t.co/UgpzPJjQcn
Our paper is out! The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis. Thanks @henok_sahile and team for your great work. #repurposing@UBC#TB#HDT https://t.co/vXIsuuj23G